簡介

本頁面提供了有關 Sunil Patel 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Sunil Patel已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:OABI / OmniAb, Inc. Director 224,265
US:LGND / Ligand Pharmaceuticals Incorporated 28,820
US:OMED / OptMed Inc See Remarks 100,000
如何解讀這些圖表

以下圖表顯示了在Sunil Patel進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Sunil Patel 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2023-02-01 2023-01-30 4 OABI OmniAb, Inc.
Common Stock
A - Award 8,753 224,265 4.06
2022-11-10 2022-11-09 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 43,000 215,512 24.93 2.77 119,110 596,968
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1,004 28,820 -3.37
2022-11-03 2022-11-01 4 OABI OmniAb, Inc.
Common Stock
A - Award 172,512 172,512
2022-06-13 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1,004 29,824 3.48
2021-06-07 2021-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,269 3,269
2021-06-07 2021-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 630 28,820 2.23
2020-11-04 2020-11-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 28,190 3.68 82.52 82,520 2,326,239
2020-06-12 2020-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,468 2,468
2020-06-12 2020-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 831 27,190 3.15
2019-08-05 2019-08-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,000 26,359 3.94 95.98 95,980 2,529,937
2019-06-07 2019-06-06 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 4,071 4,071
2019-06-07 2019-06-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 835 25,359 3.40
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,335 0 -100.00
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,335 0 -100.00
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,335 0 -100.00
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -42,287 24,524 -63.29 240.05 -10,150,808 5,886,878
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,335 66,811 12.33 32.30 236,920 2,157,995
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,335 59,476 14.07 12.53 91,908 745,234
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 7,335 52,141 16.37 10.12 74,230 527,667
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5,000 44,806 12.56 9.60 48,000 430,138
2018-07-03 2018-06-19 4/A LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,474 2,474
2018-06-21 2018-06-19 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,474 2,474
2018-06-21 2018-06-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 493 39,806 1.25
2018-01-08 2018-01-04 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 100,000 100,000
2017-10-12 2017-10-10 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -1,202 68,336 -1.73 4.24 -5,099 289,868
2017-10-12 2017-10-10 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -46 69,538 -0.07 4.27 -196 296,927
2017-10-10 2017-10-07 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 50,000 50,000
2017-10-10 2017-10-07 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
A - Award 25,000 69,584 56.07
2017-05-26 2017-05-25 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,456 2,456 113.50 278,756 278,756
2017-05-26 2017-05-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 666 39,313 1.72
2017-04-25 2017-04-23 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 60,000 60,000
2017-04-25 2017-04-23 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
A - Award 20,000 44,584 81.35
2017-04-05 2017-04-04 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -5,711 24,584 -18.85 9.06 -51,731 222,687
2017-04-05 2017-04-04 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -43 30,295 -0.14 8.87 -382 268,847
2017-01-05 2017-01-03 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 65,000 65,000
2016-10-11 2016-10-09 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
A - Award 12,500 30,338 70.08
2016-05-25 2016-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,329 2,329 119.30 277,850 277,850
2016-05-25 2016-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 622 38,647 1.64
2016-01-08 2016-01-07 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -1 17,838 -0.01 21.33 -21 380,485
2016-01-08 2016-01-06 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -69 17,839 -0.39 21.65 -1,494 386,259
2016-01-08 2016-01-06 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -2,092 17,908 -10.46 22.30 -46,653 399,359
2015-12-29 2015-12-27 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 70,000 70,000
2015-04-27 2015-04-24 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 2,754 2,754 89.75 247,172 247,172
2015-04-27 2015-04-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 925 38,025 2.49
2015-03-23 2015-03-20 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
M - Exercise -14,665 101,595 -12.61
2015-03-23 2015-03-20 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -14,665 20,000 -42.30 27.86 -408,543 557,168
2015-03-23 2015-03-20 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
M - Exercise 14,665 34,665 73.32 3.42 50,154 118,554
2015-03-23 2015-03-19 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
M - Exercise -3,335 116,260 -2.79
2015-03-23 2015-03-19 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
S - Sale -3,335 20,000 -14.29 27.34 -91,186 546,844
2015-03-23 2015-03-19 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
M - Exercise 3,335 23,335 16.68 3.42 11,406 79,806
2015-03-20 2015-03-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4,591 37,100 -11.01 74.42 -341,662 2,760,982
2014-12-22 2014-12-18 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 50,000 50,000
2014-06-05 2014-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,312 3,312 67.53 223,659 223,659
2014-06-05 2014-06-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1,151 41,691 2.84
2014-03-27 2014-03-25 4 OMED OncoMed Pharmaceuticals Inc
Common Stock
A - Award 20,000 20,000
2013-07-19 2013-07-17 4 OMED OncoMed Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 14,000 14,000
2013-06-12 2013-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7,335 7,335 32.30 236,920 236,920
2013-06-12 2013-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 1,393 40,540 3.56
2013-06-12 2013-06-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,925 39,147 8.08
2012-05-31 2012-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7,335 7,335
2012-05-31 2012-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 3,592 36,222 11.01
2012-05-31 2012-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 2,925 32,630 9.85
2012-05-24 2012-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1,249 29,705 4.39 11.39 14,221 338,221
2012-05-24 2012-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 31 28,456 0.11 11.37 352 323,545
2012-05-24 2012-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 20 28,425 0.07 11.35 227 322,567
2012-05-24 2012-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 100 28,405 0.35 11.35 1,135 322,397
2012-05-24 2012-05-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 100 28,305 0.35 11.35 1,135 321,205
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)